Condition: VAP - Ventilator Associated Pneumonia · Sponsor: Charles University, Czech Republic
HyPerMICROBE is a single-centre, controlled, randomised, prospective, superiority clinical trial to compare the efficacy of daily oral care with 3% hydrogen peroxide (Oroxid®) versus standard of care (0.2% chlorhexidine digluconate) on the cumulative incidence of lower respiratory tract microbial colonisation in mechanically ventilated adult critically ill patients.
This description comes directly from the study's public registry record.
Kateřina Rambousková, MD · +420 721 185 134 · kacakoubkova@seznam.cz
Adela Jiroudkova · +420 602 145 168 · adela.jiroudkova@ruk.cuni.cz
Always discuss trial participation with your own doctor first.
| 3rd Faculty of Medicine and FNKV | Prague, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06045429